Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pramlintide fda approval date?Dabrafenib patent expiration?How does renal function impact tigecycline's liver safety?Atorvastatin side effects heart palpitations?Does lipitor's use influence blood pressure medication type?
See the DrugPatentWatch profile for Qtern
Qtern is the brand name for a fixed-dose diabetes medicine that contains dapagliflozin + saxagliptin. The generic name is therefore dapagliflozin/saxagliptin [1].
Qtern combines: - Dapagliflozin, an SGLT2 inhibitor - Saxagliptin, a DPP-4 inhibitor Together, they target blood sugar control from two different mechanisms [1].
Usually, the medicine will be referred to by the generic combination name (dapagliflozin/saxagliptin) rather than “Qtern.” Qtern is the brand used to market that combination [1].
Other Questions About Qtern :